Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Herbal medications might be safer and more effective for hair loss than synthetic treatments.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

New cytokine-targeted therapies show promise for treating alopecia areata.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Correcting trace element imbalances may help reduce alopecia areata symptoms.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Women with certain types of hair loss may have low iron levels.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Some alternative treatments for hair loss might work, but more research is needed.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.